/DISREGARD RELEASE: AIkido Pharma Inc./

Rhea-AI Summary

AIkido Pharma has requested the public to disregard the press release dated May 4, 2022, announcing a strategic investment in Discord, Inc. The company confirmed that the news was released in error, suggesting that the information is not valid or relevant.

Positive

• None.

Negative

• The announcement of an investment in Discord, Inc. was made in error, indicating potential issues in communication or decision-making processes within AIkido Pharma.

News Market Reaction

-0.86%

1 alert

-0.86% News Effect

On the day this news was published, AIKI declined 0.86%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

We are advised by AIkido Pharma Inc. that journalists and other readers should disregard the news release, AIkido Pharma Announces Strategic Investment in Social Communications Platform Provider Discord, Inc., issued 04-May-2022 over PR Newswire. The release was issued in error.

SOURCE AIkido Pharma Inc.

FAQ

What was the press release from AIkido Pharma about on May 4, 2022?

AIkido Pharma released a statement about a strategic investment in Discord, Inc., but later clarified that the announcement was made in error.

Should investors consider the May 4, 2022, press release valid?

No, AIkido Pharma has advised that the press release should be disregarded as it was issued in error.

What does the error in the press release imply for AIkido Pharma?

The error may raise concerns about the company's internal communication and decision-making processes.

Is there any valid information from the May 4, 2022, press release regarding AIkido Pharma's investments?

No, the press release contained erroneous information and should not be considered valid.